Pages that link to "Q38054722"

The following pages link to MicroRNAs as Novel Biomarkers in Colorectal Cancer (Q38054722):

Displaying 26 items.

• MicroRNAs potential utility in colon cancer: Early detection, prognosis, and chemosensitivity (Q26799044) (← links)
• Detection of miRNA as non-invasive biomarkers of colorectal cancer (Q28082196) (← links)
• miR-191 promotes tumorigenesis of human colorectal cancer through targeting C/EBPβ. (Q35551960) (← links)
• Specific microRNAs as novel biomarkers for combination chemotherapy resistance detection of colon adenocarcinoma (Q35857777) (← links)
• Plasma levels of microRNA-24, microRNA-320a, and microRNA-423-5p are potential biomarkers for colorectal carcinoma (Q35987115) (← links)
• Personalized medicine in screening for malignant disease: a review of methods and applications (Q36641610) (← links)
• Highly sensitive, non-invasive detection of colorectal cancer mutations using single molecule, third generation sequencing (Q36717750) (← links)
• Identification of serum microRNA profiles in colon cancer (Q36889636) (← links)
• Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancer (Q37295759) (← links)
• Copy number variation in hereditary non-polyposis colorectal cancer (Q37590426) (← links)
• miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression (Q37641603) (← links)
• DNA methylation biomarkers as diagnostic and prognostic tools in colorectal cancer (Q38140769) (← links)
• MicroRNA-206 functions as a tumor suppressor in colorectal cancer by targeting FMNL2. (Q38823775) (← links)
• Current Status and Perspectives Regarding LNA-Anti-miR Oligonucleotides and microRNA miR-21 Inhibitors as a Potential Therapeutic Option in Treatment of Colorectal Cancer (Q38841033) (← links)
• Circulating exosomes and exosomal microRNAs as biomarkers in gastrointestinal cancer. (Q39041043) (← links)
• miR-141 promotes colon cancer cell proliferation by inhibiting MAP2K4. (Q42126711) (← links)
• Evolving notions on immune response in colorectal cancer and their implications for biomarker development. (Q50098505) (← links)
• Serological under expression of microRNA-21, microRNA-34a and microRNA-126 in colorectal cancer. (Q53107821) (← links)
• Molecular profiling in colorectal cancer: current state of play and future directions (Q54687516) (← links)
• RNA Biomarkers: Frontier of Precision Medicine for Cancer. (Q54955356) (← links)
• Identification of Prognostic Biomarker Signatures and Candidate Drugs in Colorectal Cancer: Insights from Systems Biology Analysis (Q61814553) (← links)
• Association between TP53 genetic polymorphisms and the methylation and expression of miR-34a, 34b/c in colorectal cancer tissues (Q64083358) (← links)
• Long Noncoding RNAs in Colorectal Adenocarcinoma; an in silico Analysis (Q89286374) (← links)
• The Role of Extracellular Vesicles as Modulators of the Tumor Microenvironment, Metastasis and Drug Resistance in Colorectal Cancer (Q92409663) (← links)
• Diagnostic Value of Combining miRNAs, CEA Measurement and the FOBT in Colorectal Cancer Screening (Q94452962) (← links)
• MicroRNA-221-3p is related to survival and promotes tumour progression in pancreatic cancer: a comprehensive study on functions and clinicopathological value (Q99565352) (← links)